A proof‐of‐concept, phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide‐releasing anti‐inflammatory drug
| Main Author: | |
|---|---|
| Format: | article |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://doi.org/10.1111/bph.14641 |
| Country: | Brazil |
| Oai: | 002991891 |